Smurfit Westrock (SW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Smurfit Westrock was formed in July 2024 from the merger of Smurfit Kappa and WestRock, creating a global leader in sustainable paper-based packaging with dual listings on NYSE and LSE and inclusion in the S&P 500.
The company reported $30.9B in net sales and $4.7B in adjusted EBITDA for 2024, with a 15.2% adjusted EBITDA margin, and operates in 40 countries with ~100,000 employees.
A $400 million synergy program is on track for completion in 2025, with additional value creation opportunities identified.
The first AGM will be held in Dublin on May 2, 2025, with shareholders invited to vote on key proposals.
Voting matters and shareholder proposals
Election of 14 director nominees for a one-year term.
Advisory vote to approve named executive officer compensation (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes, with the Board recommending annual votes.
Ratification of KPMG as independent auditor and authorization for the Audit Committee to set its remuneration.
Proposals to grant the Board authority to issue shares, opt out of statutory pre-emption rights, and set the price range for re-issuing treasury shares under Irish law.
Board of directors and corporate governance
The Board consists of 14 members, 12 of whom are independent, with a 50% gender split and diverse international backgrounds.
Key committees (Audit, Compensation, Nomination, Finance, Sustainability) are fully independent.
Annual director elections with majority voting; shareholders holding 10%+ can call special meetings.
No supermajority vote provisions or poison pill; one class of voting stock with equal rights.
Board and committee evaluations are conducted annually.
Latest events from Smurfit Westrock
- Targets $7bn Adjusted EBITDA and ~19% margin by 2030, with strong capital returns and global growth.SW
Investor presentation11 Mar 2026 - 2025 saw robust results, strong governance, and key proposals for shareholder approval.SW
Proxy Filing11 Mar 2026 - AGM to vote on directors, compensation, auditor, and share issuance; board recommends approval.SW
Proxy Filing11 Mar 2026 - Q4 net sales $7.58B, $4.94B Adjusted EBITDA; 2026 EBITDA guidance $5–$5.3B.SW
Q4 202511 Feb 2026 - Merger creates global leader; Q2 net income falls, but integration and synergies drive outlook.SW
Q2 20242 Feb 2026 - Q3 sales hit $7.7B, Adjusted EBITDA $1.27B, but one-time costs led to a $150M net loss.SW
Q3 202417 Jan 2026 - Q4 net sales $7.5B, $1.17B EBITDA, $400M synergies, and 42% dividend increase achieved.SW
Q4 20248 Jan 2026 - Q1 2025 Adjusted EBITDA rose 163% to $1.252B, with strong synergy and integration progress.SW
Q1 20256 Jan 2026 - AGM to vote on directors, executive pay, auditor, and key share issuance proposals.SW
Proxy Filing2 Dec 2025